Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM and in Number of Unplanned Visits/Hospital Admissions Due to OM

World News: . []

BEVERLY Mass April 16 2018 GLOBE NEWSWIRE -- Innovation Pharmaceuticals (OTCQB:IPIX) the Company a clinical stage biopharmaceutical company, is pleased to report additional information from the Company’s successfully completed Pha se 2 cl...

More news and information about Innovation Pharmaceuticals, Inc.

Published By:

Globe Newswire: 15:45 GMT Monday 16th April 2018

Published: .

Search for other references to "innovation" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us